BioSpace News Archive

NJ Health Dept., Hospital Assoc. Have Posted Guidance for Doctors, Patients

Medifast, Inc. (NYSE: MED), a leading developer of clinically proven health and wellness programs, products and services, today reported strong results for the second quarter ended June 30, 2019.

DaVita Inc. (NYSE: DVA) today announced results for the quarter ended June 30, 2019.

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) (BioMarin or the Company) today announced financial results for the second quarter ended June 30, 2019.

DURECT Corporation (Nasdaq: DRRX) today announced financial results for the three months ended June 30, 2019 and provided a corporate update.

Natural Grocers by Vitamin Cottage, Inc. (NYSE: NGVC) today announced results for its third quarter of fiscal 2019 ended June 30, 2019, raised the midpoint of its fiscal 2019 diluted earnings per share outlook and narrowed its 2019 daily average comparable store sales guidance.

Mettler-Toledo International Inc. (NYSE: MTD) today announced second quarter results for 2019.

Intersect ENT, Inc. (NASDAQ:XENT), a company dedicated to transforming care for patients with ear, nose and throat conditions, today reported financial results for the second quarter ended June 30, 2019.

Verastem, Inc. (Nasdaq: VSTM), operating as Verastem Oncology (or “the Company”), focused on developing and commercializing medicines seeking to improve the survival and quality of life of cancer patients, today reported financial results for the three months ended June 30, 2019, and provided an overview of recent accomplishments and clinical development progress for duvelisib (COPIKTRA®).

Correvio Pharma Corp. (NASDAQ: CORV) (TSX: CORV), a specialty pharmaceutical company focused on commercializing hospital drugs, today announced that it has undertaken an overnight marketed underwritten public offering (the “Offering”) of its common shares